
Tryptase as a Biomarker for Adverse Prognosis in ST-Segment Elevation Myocardial Infarction Patients: A Prospective ...
Introduction Acute ST-segment elevation myocardial infarction (STEMI) is the most severe type in coronary heart disease. Primary percutaneous coronary intervention (PPCI) is a critical treatment for STEMI.1,2 Plaque rupture, thrombosis and reperfusion …